Most Recent
Merck Sharp & Dohme, Wyeth gear up for trial over vaccine patents
Intellectual Property 2018-09-28 10:43 pm By Miklos Bolza

Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the Prevnar pneumococcal disease vaccine are underway, and […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Alphapharm can’t get docs ahead of hearing on injector pen injunction
Intellectual Property 2018-09-18 9:41 pm By Cat Fredenburgh

Generic drug company Alphapharm has lost a bid for documents it claimed would show Sanofi-Aventis suspected as early as 2015 that patents for one of […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Aristocrat patent appeal hinges on Rokt, Encompass outcomes
Intellectual Property 2018-09-13 10:42 pm By Miklos Bolza

A Federal Court judge has put an appeal by Aristocrat of an IP Australia ruling that revoked four of its gaming patents on hold pending […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

VisionSearch takes final shot at ObjectiVision’s ‘limited’ case
Intellectual Property 2018-09-06 10:58 pm By Miklos Bolza

ObjectiVision has presented a “limited” and “debatable” case that its source code for a glaucoma testing device was copied, the Federal Court heard Thursday as […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

ObjectiVision wraps up IP trial against University of Sydney
Intellectual Property 2018-09-04 10:25 pm By Miklos Bolza

Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Alphapharm says Sanofi patent amendment should doom injunction bid
Intellectual Property 2018-08-30 9:13 pm By Miklos Bolza

Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Guard rail maker wins ruling invalidating rival’s patent
Intellectual Property 2018-08-22 11:34 pm By Cat Fredenburgh

A maker of guard rails used on highways has won a judgment invalidating a rival’s patent, with a judge finding the patent lacks novelty. Justice […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Foxtel should pay more than a gym to stream copyrighted recordings, court told
Intellectual Property 2018-08-15 10:06 pm By Miklos Bolza

A Copyright Tribunal decision that led to substantially lower sound recording licence fees for Foxtel was “beyond the pale” because it compared fees charged to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

ObjectiVision can’t overhaul claims in University of Sydney spat over AccuMap
Intellectual Property 2018-08-10 3:46 pm By Miklos Bolza

Ophthalmic diagnostic device manufacturer ObjectiVision can’t file amended claims for damages following a trial in a copyright and contract case against the University of Sydney, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

University of Sydney slams ObjectiVision’s ‘outlandish’ damages claims
Intellectual Property 2018-08-03 11:40 pm By Miklos Bolza

Ophthalmic diagnostic device maker ObjectiVision’s amended claims for damages, filed after a 25-day patent hearing, are “outlandish” and “unfair,” the University of Sydney has told […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.